Status:

COMPLETED

B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient

Lead Sponsor:

Emory University

Conditions:

Heart Diseases

Eligibility:

All Genders

1-5 years

Brief Summary

B-type Natriuretic Peptide (BNP) is a hormone that is made by the pumping chambers of the heart. The BNP level can be measured by a blood test and is used as a marker for heart problems in adults. Dec...

Detailed Description

Introduction At Children's Healthcare of Atlanta, thousands of children are seen in the Emergency Department (ED) each year for evaluation and treatment. Deciding if a child has a cardiac or pulmonary...

Eligibility Criteria

Inclusion

  • Any child presenting to the pediatric ED at Children's Healthcare of Atlanta (CHOA)at Egleston undergoing evaluation for respiratory and/or infectious disease.
  • Patient age is less than 6 years old.
  • Patients having venipuncture for lab studies as a part of the ED admission.
  • Informed consent being obtained from the legal guardians.

Exclusion

  • Patients with known congenital or acquired heart disease.
  • Patients with previously diagnosed systemic disease such as malignancy, HIV, cystic fibrosis, organ transplant recipients.
  • Patients that will not be having venipuncture for lab studies as a part of the ED admission.
  • Trauma patients or those presenting with broken bones, dog bites, etc. (non-infectious presentation.)

Key Trial Info

Start Date :

April 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT00330811

Start Date

April 1 2006

End Date

May 1 2007

Last Update

December 2 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Healthcare of Atlanta

Atlanta, Georgia, United States, 30322